{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:26:29Z","timestamp":1792736789978,"version":"4.5.0"},"reference-count":165,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.antiviral.2008.01.004","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T13:22:27Z","timestamp":1202217747000},"page":"9-25","source":"Crossref","is-referenced-by-count":115,"title":["Molecular strategies to inhibit the replication of RNA viruses"],"prefix":"10.1016","volume":"78","author":[{"given":"Pieter","family":"Leyssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2008.01.004_bib1","first-page":"776","article-title":"Synthesis of influenza neuraminidase inhibitors","volume":"4","author":"Abdel-Magid","year":"2001","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.antiviral.2008.01.004_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0042-6822(03)00144-2","article-title":"Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis","volume":"311","author":"Airaksinen","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.004_bib3","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2008.01.004_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0166-3542(90)90009-V","article-title":"Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro","volume":"14","author":"Andrei","year":"1990","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0166-3542(93)90085-W","article-title":"Molcular approaches for the treatment of hemorrhagic fever virus infections","volume":"22","author":"Andrei","year":"1993","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jhep.2005.05.032","article-title":"Mutagenic effects of ribavirin and response to interferon\/ribavirin combination therapy in chronic hepatitis C","volume":"43","author":"Asahina","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib7","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1073\/pnas.140220397","article-title":"Mechanism of action of a pestivirus antiviral compound","volume":"97","author":"Baginski","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2008.01.004_bib8","doi-asserted-by":"crossref","first-page":"24591","DOI":"10.1016\/S0021-9258(19)74507-4","article-title":"Eicar (5-ethynyl-1-beta-d-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis","volume":"268","author":"Balzarini","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2008.01.004_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrmicro1707","article-title":"Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy","volume":"5","author":"Balzarini","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/095632020701800101","article-title":"Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?","volume":"18","author":"Balzarini","year":"2007","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JVI.01404-06","article-title":"Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus","volume":"81","author":"Balzarini","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2006.03.001","article-title":"Enhancement of the infectivity of SARS-CoV in BALB\/c mice by IMP dehydrogenase inhibitors, including ribavirin","volume":"71","author":"Barnard","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2008.01.152","article-title":"Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions","volume":"78","author":"Bausch","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2008.01.003","article-title":"Current and future antiviral therapy of severe seasonal and avian influenza","volume":"78","author":"Beigel","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib15","doi-asserted-by":"crossref","first-page":"35638","DOI":"10.1074\/jbc.M400460200","article-title":"A structural basis for the inhibition of the NS5 dengue virus mRNA 2\u2032-O-methyltransferase domain by ribavirin 5\u2032-triphosphate","volume":"279","author":"Benarroch","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2008.01.004_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/AAC.49.2.619-626.2005","article-title":"Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor","volume":"49","author":"Binford","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.antiviral.2008.01.004_bib17","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1128\/AAC.00905-07","article-title":"In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease","volume":"51","author":"Binford","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2005.10.008","article-title":"Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses","volume":"69","author":"Bolken","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/095632020701800206","article-title":"Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase\/helicase","volume":"18","author":"Borowski","year":"2007","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib20","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.2807\/esm.09.12.00504-en","article-title":"Task force on biological and chemical agent threats, Public Health Directorate, European Commission, Luxembourg. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses","volume":"9","author":"Bossi","year":"2004","journal-title":"Eur. Surveill."},{"key":"10.1016\/j.antiviral.2008.01.004_bib21","doi-asserted-by":"crossref","first-page":"52471","DOI":"10.1074\/jbc.M308917200","article-title":"Initial binding of the broad spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase","volume":"278","author":"Bougie","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2008.01.004_bib22","doi-asserted-by":"crossref","first-page":"22124","DOI":"10.1074\/jbc.M400908200","article-title":"The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme","volume":"279","author":"Bougie","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2008.01.004_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2007.12.007","article-title":"Highly pathogenic RNA viral infections: challenges for antiviral research","volume":"78","author":"Bray","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-3542(00)00066-8","article-title":"Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-l-homocysteine hydrolase inhibitor","volume":"45","author":"Bray","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-3542(02)00018-9","article-title":"3-Deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice","volume":"55","author":"Bray","year":"2002","journal-title":"Antivir. Res."},{"issue":"9492","key":"10.1016\/j.antiviral.2008.01.004_bib26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.004_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2003.09.005","article-title":"In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination","volume":"61","author":"Briolant","year":"2004","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib28","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1126\/science.186.4170.1172","article-title":"Viral infection and host defense","volume":"186","author":"Carter","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2008.01.004_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/135965359900400404","article-title":"Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience","volume":"4","author":"Chapman","year":"1999","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2008.01.004_bib30","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/AAC.00211-07","article-title":"RSV604, a novel inhibitor of respiratory syncytial virus replication","volume":"51","author":"Chapman","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"14","key":"10.1016\/j.antiviral.2008.01.004_bib31","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.1128\/JVI.00382-07","article-title":"Analysis of ribavirin mutagenicity in human hepatitis C virus infection","volume":"81","author":"Chevaliez","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib32","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3748\/wjg.v13.i17.2461","article-title":"Hepatitis C virus: virology, diagnosis and management of antiviral therapy","volume":"13","author":"Chevaliez","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib33","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ana.1062","article-title":"Treatment of acute Nipah encephalitis with ribavirin","volume":"49","author":"Chong","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib34","doi-asserted-by":"crossref","first-page":"A39","DOI":"10.1016\/j.antiviral.2007.01.037","article-title":"The cyclophilin inhibitor Debio-025 is a potent inhibitor of hepatitis C virus replication in vitro with a unique resistance profile","volume":"74","author":"Coelmont","year":"2007","journal-title":"Antivir. Res."},{"issue":"9","key":"10.1016\/j.antiviral.2008.01.004_bib35","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/425007","article-title":"Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America","volume":"39","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.004_bib36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"Crotty","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2008.01.004_bib37","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2008.01.004_bib38","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.144.3620.862","article-title":"Antiviral activity of 1-adamantanamine (amantadine)","volume":"144","author":"Davies","year":"1964","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2008.01.004_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-2952(90)90031-F","article-title":"Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine","volume":"39","author":"De Clercq","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib40","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/0006-2952(91)90120-T","article-title":"Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase","volume":"41","author":"De Clercq","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2005.05.001","article-title":"Antiviral drug discovery and development: where chemistry meets with biomedicine","volume":"67","author":"De Clercq","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib42","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nrd2175","article-title":"Antiviral agents active against influenza A viruses","volume":"5","author":"De Clercq","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2008.01.004_bib43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nature04080","article-title":"Challenges and successes in developing new therapies for hepatitis C","volume":"436","author":"De Francesco","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.004_bib44","unstructured":"De Palma, A.M., Vliegen, I., De Clercq, E., Neyts, J. Selective inhibitors of picornaviruses, submitted for publication."},{"key":"10.1016\/j.antiviral.2008.01.004_bib45","unstructured":"De Palma, A.M., Heggermont, W., Lanke, K., Coutard, C., Canard, B., De Clercq, E., Chimirri, A., Rohayem, J., Norder, H., Van Kuppeveld, F., Neyts, J. TBZ inhibits replication of enterovirus species B and D by targeting a short conserved domain in the non-structural protein 2C. J. Virol., accepted for publication."},{"key":"10.1016\/j.antiviral.2008.01.004_bib46","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2006.12.063","article-title":"Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H, 3H-thiazolo[3,4-a]benzimidazoles","volume":"353","author":"De Palma","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2008.01.004_bib47","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1128\/JVI.79.13.8669-8674.2005","article-title":"In vitro assembly of PB2 with a PB1-PA dimer supports a new model of assembly of influenza A virus polymerase subunits into a functional trimeric complex","volume":"79","author":"Deng","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib48","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nature03153","article-title":"Modelling how ribavirin improves interferon response rates in hepatitis C virus infection","volume":"432","author":"Dixit","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.004_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrd708","article-title":"Targeting glycosylation as a therapeutic approach","volume":"1","author":"Dwek","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2008.01.004_bib50","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1128\/JVI.77.9.5054-5064.2003","article-title":"Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein","volume":"77","author":"Douglas","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib51","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.49.6.2460-2466.2005","article-title":"Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms","volume":"49","author":"Douglas","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib52","first-page":"55","article-title":"The therapeutic efficacy of ribamidil and virazole in experimental Lassa fever in monkeys","volume":"36","author":"Dvoretskaia","year":"1991","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib53","doi-asserted-by":"crossref","first-page":"12772","DOI":"10.1073\/pnas.0701478104","article-title":"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus","volume":"104","author":"Dwyer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2008.01.004_bib54","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/emboj\/21.11.2757","article-title":"An RNA cap (nucleoside-2\u2032-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization","volume":"21","author":"Egloff","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2008.01.004_bib55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jmb.2007.07.005","article-title":"Structural and functional analysis of methylation and 5\u2032-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5","volume":"372","author":"Egloff","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib56","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","article-title":"Treatment of argentine hemorrhagic fever","volume":"78","author":"Enria","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2007.11.002","article-title":"Treatment of Crimean-Congo hemorrhagic fever","volume":"78","author":"Ergonul","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib58","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1128\/AAC.11.6.946","article-title":"Inhibition of influenza virus ribonucleic acid polymerase by ribavirintriphosphate","volume":"11","author":"Eriksson","year":"1977","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jat.938","article-title":"Effect of ribavirin, levovirin and viramidine on liver toxicological gene expression in rats","volume":"23","author":"Fang","year":"2003","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib60","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(95)91323-8","article-title":"Crimean Congo-haemorrhagic fever treated with oral ribavirin","volume":"346","author":"Fisher-Hoch","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.004_bib61","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.21774","article-title":"Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C","volume":"46","author":"Forestier","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2008.01.004_bib62","first-page":"1","article-title":"The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target","volume":"9","author":"Frick","year":"2007","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib63","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib64","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib65","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/bi0271401","article-title":"The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase","volume":"42","author":"Gan","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2008.01.004_bib66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bmc.2004.09.036","article-title":"Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases","volume":"13","author":"Ganesh","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2008.01.004_bib67","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/AAC.50.5.1768-1772.2006","article-title":"Poly-(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection","volume":"50","author":"Georges-Courbot","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.antiviral.2006.09.007","article-title":"2\u2032-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus","volume":"73","author":"Goris","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib69","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.antiviral.2007.10.003","article-title":"Potential of antiviral prophylaxis and therapy for controlling RNA viral infections of livestock","volume":"78","author":"Goris","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib70","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0006-291X(79)91853-9","article-title":"The broad spectrum antiviral agent ribavirin inhibits capping of mRNA","volume":"89","author":"Goswami","year":"1979","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2008.01.004_bib71","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2007.10.005","article-title":"Does antiviral therapy have a role in the control of Japanese encephalitis?","volume":"78","author":"Gould","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2007.10.002","article-title":"Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses","volume":"78","author":"Gowen","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib73","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","article-title":"In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections","volume":"51","author":"Gowen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/3-540-26764-6_4","article-title":"Nuclear import in viral infections","volume":"285","author":"Greber","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.antiviral.2004.05.001","article-title":"Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro","volume":"63","author":"Gunther","year":"2004","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.antiviral.2008.01.004_bib77","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2007.08.007","article-title":"Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China","volume":"77","author":"He","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2007.10.004","article-title":"Animal models of highly pathogenic RNA viral infections: encephalitis viruses","volume":"78","author":"Holbrook","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib79","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrmicro1208","article-title":"Influenza: lessons from past pandemics, warnings from current incidents","volume":"3","author":"Horimoto","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib80","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0166-3542(89)90072-7","article-title":"Inhibitory effect of selected antiviral compounds on measeles (SSPE) virus replication in vitro","volume":"12","author":"Hosoya","year":"1989","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib81","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/AAC.26.4.476","article-title":"Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses","volume":"26","author":"Huggins","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2008.01.004_bib82","doi-asserted-by":"crossref","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug","volume":"11","author":"Huggins","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.004_bib83","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/infdis\/164.6.1119","article-title":"Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome","volume":"164","author":"Huggins","year":"1991","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2008.01.004_bib84","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/514316","article-title":"Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model","volume":"179","author":"Huggins","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.004_bib85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/AAC.3.2.235","article-title":"In vitro effect of 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses","volume":"3","author":"Huffman","year":"1973","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib86","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/infdis\/141.5.580","article-title":"Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin","volume":"141","author":"Jahrling","year":"1980","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.004_bib87","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus","volume":"176","author":"Johnson","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.004_bib88","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.antiviral.2007.10.012","article-title":"Treatment of hantavirus pulmonary syndrome","volume":"78","author":"Jonsson","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib89","first-page":"162","article-title":"Targeting hepatitis C virus translation: stopping HCV where it starts","volume":"4","author":"Jubin","year":"2003","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.antiviral.2008.01.004_bib90","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/AAC.31.8.1225","article-title":"Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro","volume":"31","author":"Kawana","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib91","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2007.11.003","article-title":"New opportunities for field research on the pathogenesis and treatment of Lassa fever","volume":"78","author":"Khan","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib92","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/ja963036t","article-title":"Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity","volume":"119","author":"Kim","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2008.01.004_bib93","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1074\/jbc.M510195200","article-title":"The novel nucleoside analog R1479 (4\u2032-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture","volume":"281","author":"Klumpp","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2008.01.004_bib94","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature02099","article-title":"An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus","volume":"426","author":"Lamarre","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.004_bib95","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1128\/JVI.75.17.8074-8081.2001","article-title":"Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes","volume":"75","author":"Lanford","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib96","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib97","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1124\/mol.105.020057","article-title":"The anti-yellow fever virus activity of ribavirin is independent of error-prone replication","volume":"69","author":"Leyssen","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib98","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1128\/AAC.00118-06","article-title":"Absorption, metabolism, and excretion of [14C]viramidine in humans","volume":"50","author":"Lin","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2008.01.004_bib99","first-page":"385A","article-title":"Mutation rate of hepatitis C virus in patients during ribavirin monotherapy","volume":"40","author":"Lutchman","year":"2004","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.antiviral.2008.01.004_bib100","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1016\/j.bmc.2007.08.049","article-title":"Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2\u2032O)-methyltransferase","volume":"15","author":"Luzhkov","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"49","key":"10.1016\/j.antiviral.2008.01.004_bib101","doi-asserted-by":"crossref","first-page":"46094","DOI":"10.1074\/jbc.C100349200","article-title":"Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin","volume":"276","author":"Maag","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2008.01.004_bib102","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.50.4.1470-1479.2006","article-title":"Sialidase fusion protein as a novel broadspectrum inhibitor of influenza virus infection","volume":"50","author":"Malakhov","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib103","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0042-6822(81)90060-X","article-title":"Inhibitors of IMP dehydrogenase prevent sindbis virus replication and reduce GTP levels in Aedes albopictus cells","volume":"30","author":"Malinoski","year":"1981","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.004_bib104","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/375058","article-title":"The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran","volume":"36","author":"Mardani","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.004_bib105","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.44.4.859-866.2000","article-title":"Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon","volume":"44","author":"Markland","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib106","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/jm00117a004","article-title":"Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties","volume":"31","author":"Marquez","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2008.01.004_bib107","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.004_bib108","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.32.9.1304","article-title":"Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever","volume":"32","author":"McKee","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib109","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antivir. Res."},{"issue":"16","key":"10.1016\/j.antiviral.2008.01.004_bib110","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0264-410X(03)00075-6","article-title":"The role of antivirals in the control of influenza","volume":"21","author":"Monto","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2008.01.004_bib111","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1021\/jm00348a004","article-title":"Carbocyclic analogue of 3-deazaadenosine: a novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological target","volume":"25","author":"Montgomery","year":"1982","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2008.01.004_bib112","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI25669","article-title":"Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease","volume":"115","author":"Moscona","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2008.01.004_bib113","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"29","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.004_bib114","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1006\/jmbi.2000.3924","article-title":"Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design","volume":"301","author":"Murthy","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib115","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbrc.2005.03.062","article-title":"Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha","volume":"13","author":"Naka","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2008.01.004_bib116","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2003.11.080","article-title":"Specific inhibition of hepatitis C virus replication by cyclosporin A","volume":"313","author":"Nakagawa","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2008.01.004_bib117","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/j.gastro.2005.06.031","article-title":"Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins","volume":"129","author":"Nakagawa","year":"2005","journal-title":"Gastroenterology"},{"issue":"2\u20133","key":"10.1016\/j.antiviral.2008.01.004_bib118","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-3542(96)89697-5","article-title":"Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections","volume":"30","author":"Neyts","year":"1996","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib119","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/hep.21102","article-title":"The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro","volume":"43","author":"Paeshuyse","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2008.01.004_bib120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/JVI.80.1.149-160.2006","article-title":"A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase","volume":"80","author":"Paeshuyse","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib121","doi-asserted-by":"crossref","first-page":"11046","DOI":"10.1128\/JVI.00388-07","article-title":"The imidazopyrrolopyridine analogue AG110 is a novel, highly selective inhibitor of pestiviruses that targets the viral RNA-dependent RNA polymerase at a hot spot for inhibition of viral replication","volume":"81","author":"Paeshuyse","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib122","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.49.6.2267-2275.2005","article-title":"In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease","volume":"49","author":"Patick","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib123","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.antiviral.2006.03.011","article-title":"Rhinovirus chemotherapy","volume":"71","author":"Patick","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib124","doi-asserted-by":"crossref","first-page":"20374","DOI":"10.1074\/jbc.M210785200","article-title":"An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA","volume":"278","author":"Pause","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2008.01.004_bib125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0168-8278(04)90062-1","article-title":"Is ribavirin antiviral effect in humans mediated b mutagenic properties resulting in error catastrophe?","volume":"40","author":"Pawlotsky","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib126","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1053\/j.gastro.2003.12.002","article-title":"Antiviral action of ribavirin in chronic hepatitis C","volume":"126","author":"Pawlotsky","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2008.01.004_bib127","doi-asserted-by":"crossref","first-page":"9837","DOI":"10.1128\/JVI.00736-06","article-title":"Inhibition of hendra virus fusion","volume":"80","author":"Porotto","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib128","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1073\/pnas.1232294100","article-title":"A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity","volume":"100","author":"Pfeiffer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2008.01.004_bib129","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.1977.tb21977.x","article-title":"Antiviral action and selectivity of 6-azauridine","volume":"284","author":"Rada","year":"1977","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2008.01.004_bib130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0042-6822(89)90413-3","article-title":"Studies on the mechanism of the antiviral activity of ribavirin against reovirus","volume":"168","author":"Rankin","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.004_bib131","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/hep.20975","article-title":"Treating hepatitis C: can you teach old dogs new tricks?","volume":"42","author":"Rice","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2008.01.004_bib132","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.004_bib133","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2005.01.003","article-title":"Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus","volume":"66","author":"Saijo","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib134","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0042-6822(91)90881-B","article-title":"Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the nonstructural protein nsP1","volume":"181","author":"Scheidel","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.004_bib135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/135965350300800603","article-title":"The potentiating effect of ribavirin on interferon in the treatment of hepatitis C: lack of evidence for ribavirin-induced viral mutagenesis","volume":"8","author":"Schinkel","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2008.01.004_bib136","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1286-4579(01)01508-8","article-title":"Monitoring of clinical and laboratory data in two cases of imported Lassa fever","volume":"4","author":"Schmitz","year":"2002","journal-title":"Microb. Infect."},{"key":"10.1016\/j.antiviral.2008.01.004_bib137","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1128\/JVI.77.1.481-488.2003","article-title":"Ribavirin causes error catastrophe during Hantaan virus replication","volume":"77","author":"Severson","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib138","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1128\/AAC.20.6.769","article-title":"Evaluation of carbodine, the carbocyclic analog of cytidine, and related carbocyclic analogs of pyrimidine nucleosides for antiviral activity against human influenza type A viruses","volume":"20","author":"Shannon","year":"1981","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib139","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/AAC.32.6.906","article-title":"Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro","volume":"32","author":"Shigeta","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/AAC.3.2.242","article-title":"Effect of 1-beta-d-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals","volume":"3","author":"Sidwell","year":"1973","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib141","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2005.06.003","article-title":"In vitro and in vivo influenza virus-inhibitory effects of viramidine","volume":"68","author":"Sidwell","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib142","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/AAC.01051-06","article-title":"Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice","volume":"51","author":"Sidwell","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib143","doi-asserted-by":"crossref","first-page":"10211","DOI":"10.1128\/JVI.78.18.10211.2004","article-title":"Ribavirin therapy for Nipah virus infection","volume":"78","author":"Snell","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib144","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2007.12.008","article-title":"Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viral infections","volume":"78","author":"Spurgers","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0140-6736(79)90790-6","article-title":"Experimental Lassa fever virus infection successfully treated with ribavirin","volume":"1","author":"Stephen","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.004_bib146","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2008.01.004_bib147","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1073\/pnas.70.4.1174","article-title":"Mechanism of action of 1-\u03b2-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent","volume":"70","author":"Streeter","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2008.01.004_bib148","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/095632020201300602","article-title":"Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents","volume":"13","author":"Stuyver","year":"2002","journal-title":"Antivir. Chem. Chemother."},{"issue":"5","key":"10.1016\/j.antiviral.2008.01.004_bib149","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/095632020301400502","article-title":"In vitro and in vivo activities of T-705 and oseltamivir against influenza virus","volume":"14","author":"Takahashi","year":"2003","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(99)80093-2","article-title":"Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile","volume":"30","author":"Tam","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib151","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1128\/AAC.44.5.1276-1283.2000","article-title":"The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels","volume":"44","author":"Tam","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib152","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1128\/AAC.39.11.2454","article-title":"Inhibition of influenza virus transcription by 2\u2032-deoxy-2\u2032-fluoroguanosine","volume":"39","author":"Tisdale","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib153","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1128\/AAC.40.5.1189","article-title":"A novel antiviral agent which inhibits the endonuclease of influenza viruses","volume":"40","author":"Tomassini","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib154","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.bmcl.2007.01.074","article-title":"An analogue of AICAR with dual inhibitory activity against WNV and HCV NTPase\/helicase: synthesis and in vitro screening of 4-carbamoyl-5-(4,6-diamino-2,5-dihydro-1,3,5-triazin-2-yl)imidazole-1-beta-d-ribofuranoside","volume":"17","author":"Ujjinamatada","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2008.01.004_bib155","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/dkm301","article-title":"The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavirus envelope glycoproteins","volume":"60","author":"van der Meer","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib156","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000181.pub3","article-title":"Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children","volume":"24","author":"Ventre","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.antiviral.2008.01.004_bib157","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"von Itzstein","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.004_bib158","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molcel.2005.05.014","article-title":"Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase","volume":"19","author":"Watashi","year":"2005","journal-title":"Mol. Cell."},{"key":"10.1016\/j.antiviral.2008.01.004_bib159","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4269\/ajtmh.1989.41.581","article-title":"Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin","volume":"41","author":"Watts","year":"1989","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2008.01.004_bib160","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1128\/JVI.76.8.3596-3604.2002","article-title":"Antiviral effects of an iminosugar derivative on flavivirus infections","volume":"76","author":"Wu","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib161","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/095632020601700105","article-title":"Conversion of viramidine to ribavirin in vivo by adenosine deaminase and its inhibition by 2\u2032-deoxycoformycin","volume":"17","author":"Wu","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2008.01.004_bib162","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jsb.2006.03.024","article-title":"Biophysical characterization of HRC peptide analogs interaction with heptad repeat regions of the SARS-Coronavirus Spike fusion protein core","volume":"155","author":"Yan","year":"2006","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.antiviral.2008.01.004_bib163","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-3542(04)00202-5","article-title":"Inhibition of bovine viral diarrhea virus (BVDV) by mizoribine: synergistic effect of combination with interferon-alpha","volume":"64","author":"Yanagida","year":"2004","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.004_bib164","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1073\/pnas.1835675100","article-title":"The crystal structures of severe acute respiratory syndrome virus main proteaseand its complex with an inhibitor","volume":"100","author":"Yang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2008.01.004_bib165","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:37:58Z","timestamp":1684222678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354208000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":165,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0166354208000247"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2008.01.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}